Drug–drug interactions in HIV-infected patients receiving chemotherapy

Chrystalyn Branch,Jan Parson-Martinez,Theodore James Cory
DOI: https://doi.org/10.1080/17425255.2024.2408004
2024-09-26
Expert Opinion on Drug Metabolism & Toxicology
Abstract:Introduction Coadministration of antiretrovirals and anti-cancer medications may present many complex clinical scenarios. This is characterized by the potential for drug–drug interactions (DDIs) and the challenges that arise in patient management. In this article, we investigate the potential for DDIs between antiretrovirals, including protease inhibitors (PIs), non-nucleoside reverse transcriptase inhibitors, nucleoside reverse transcriptase inhibitors (NRTIs), integrase strand transfer inhibitors (INSTIs), and anti-cancer medications.
pharmacology & pharmacy,biochemistry & molecular biology,toxicology
What problem does this paper attempt to address?